Effects of Whole-body Electromyostimulation and Dietary Supplements on "Sarcopenic Obesity"

Effects of Whole-body Electromyostimulation and Dietary Supplements on "Sarcopenic Obesity" in Elderly Females Living in the Community

The aim of the study is to determine the effect of whole body electromyostimulation (WB-EMS) and/or nutritional on body composition and functional tasks in elderly females with sarcopenic obesity. Seventy-five, non-sportive, independently living women 70 years and older with Sarcopenic Obesity were randomly assigned to either a WB-EMS group ( n=25), a WB-EMS/nutritional supplements (n=25) or a semi-active control group (an=25). The WB-EMS protocol applied one session of 18 min/week of WB-EMS (bipolar, 85 Hz). Nutritional strategy based on a high protein supplement.

Study Overview

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Phase 2
  • Phase 3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • community dwelling
  • Sarcopenic Obesity

Exclusion Criteria:

  • exercising more than 60 min/week
  • more than 4 weeks absent during the interventional period,
  • injuries (i.e. hip TotalEndoProsthesis (TEP), abdomen/groin hernia) or diseases (i.e. epilepsy, cardiac arrhythmia) that prevent WB-EMS intervention
  • medication and/or diseases affecting our primary endpoints.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Whole body Electromyostimulation (WB-EMS)
18 min of WB-EMS/week (one session/week)
Supervised WB-EMS Intervention 18 min/session (one session/week) and monthly dietary counseling for 6 months
Active Comparator: WB-EMS and Nutritional Supplements
18 min of WB-EMS/week (one session/week) and supplements with high protein (Leucin) contents
Supervised WB-EMS Intervention and dietary supplementation and monthly dietary counseling for 6 months
Sham Comparator: Control
Monthly dietary counseling for 6 months
Monthly dietary counseling only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appendicular skeletal muscle mass
Time Frame: baseline - 6 months follow-up
changes of appendicular skeletal muscle mass from baseline to 6 month follow-up
baseline - 6 months follow-up
Muscle density of the medial thigh
Time Frame: baseline - 6 months follow-up
changes of muscle density (thigh) from baseline to 6 month follow-up
baseline - 6 months follow-up
Intramuscular fat content
Time Frame: baseline - 6 months follow-up
changes of Intramuscular fat content (thigh) from baseline to 6 month follow-up
baseline - 6 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle cross sectional area (CSA)
Time Frame: baseline - 6 months follow-up
changes of muscle CSA (thigh) from baseline to 6 month follow-up
baseline - 6 months follow-up
Isokinetic leg strength
Time Frame: baseline - 6 months follow-up
changes of isokinetic leg strength from baseline to 6 month follow-up
baseline - 6 months follow-up
Short Physical Performance Battery (SPPB)
Time Frame: baseline - 6 months follow-up
SPPB according to Guralnik et al. (J Gerontol Med Sci1994; 49(2):M85-M94)
baseline - 6 months follow-up
Hand grip of the dominant hand
Time Frame: baseline - 6 months follow-up
Maximum isometric strength of the dominant hand (dynamometer)
baseline - 6 months follow-up
muscular power of the legs
Time Frame: baseline - 6 months follow-up
Muscular power of the legs (jumping test), by Leonardo (Novotec, Germany)
baseline - 6 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance according to SPPB
Time Frame: baseline - 6 months follow-up
Balance according to SPPB (see above), Soehnle balance platform device (Soehnle Germany)
baseline - 6 months follow-up
Quality of life
Time Frame: baseline - 6 months follow-up
Quality of Life: EUROQuOI questionnaire
baseline - 6 months follow-up
Trial Making Tests A and B
Time Frame: baseline - 6 months follow-up
TMT-L: Trail Making Test - Langensteinbacher version.
baseline - 6 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Cornel Sieber, MD, Institute of Biomedicine of Age, University of Erlangen-Nuremberg
  • Study Chair: Cornelius Bollheimer, MD, Institute of Biomedicine of Age, University of Erlangen-Nuremberg
  • Study Director: Klaus Engelke, PhD, Institute of Medical Physics, University of Erlangen-Nuremberg
  • Principal Investigator: Wolfgang Kemmler, PHD, Institute of Medical Physics, University of Erlangen-Nuremberg
  • Principal Investigator: Ellen Freiberger, PhD, Institute of Biomedicine of Age, University of Erlangen-Nuremberg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

January 21, 2015

First Submitted That Met QC Criteria

February 4, 2015

First Posted (Estimate)

February 5, 2015

Study Record Updates

Last Update Posted (Estimate)

May 23, 2016

Last Update Submitted That Met QC Criteria

May 20, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenic Obesity

Clinical Trials on WB-EMS Intervention

Subscribe